Celltrion USA
Celltrion USA
1 Evertrust Plaza, Suite 1207,
Jersey City, NJ, 07302
Phone: 1-800-560-9414Website: https://www.celltrionusa.com/Careers: www.celltrionusa.com/board/recruitinglist
Latest news
- FDA Approves Expanded Indication for Avtozma (tocilizumab-anoh) Intravenous (IV) Formulation in Cytokine Release Syndrome (CRS)
6 August 2025 - Celltrion Announces U.S. FDA Approval of Additional Presentation of Steqeyma (ustekinumab-stba), Expanding Dosing Options for Pediatric Patients
15 June 2025 - Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths
23 May 2025 - FDA Grants Interchangeable Designation to Yuflyma (adalimumab-aaty), Celltrion's Biosimilar to Humira (adalimumab)
14 April 2025 - FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair
7 March 2025 - FDA Approves Osenvelt (denosumab-bmwo), a Biosimilar to Xgeva
3 March 2025 - FDA Approves Stoboclo (denosumab-bmwo), a Biosimilar to Prolia
3 March 2025 - FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra
30 January 2025 - FDA Approves Steqeyma (ustekinumab-stba), a Biosimilar to Stelara
17 December 2024 - Zymfentra demonstrated long-term efficacy and safety profile of maintenance treatment for adults with moderately to severely active Crohn's disease and ulcerative colitis
21 May 2024
Drugs Associated with Celltrion USA
Celltrion USA manufactures, markets and/or distributes more than 17 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Avtozma
Generic name: tocilizumab Drug class: interleukin inhibitors |
||
|
famotidine
Generic Drug class: H2 antagonists |
174 reviews | 4.5 / 10 |
|
Herzuma
Generic name: trastuzumab Drug class: HER2 inhibitors |
||
|
Inflectra
Generic name: infliximab Drug class: TNF alfa inhibitors |
31 reviews | 4.0 / 10 |
|
levofloxacin
Generic Drug class: quinolones and fluoroquinolones |
741 reviews | 5.1 / 10 |
|
memantine
Generic Drug class: miscellaneous central nervous system agents |
108 reviews | 6.4 / 10 |
|
Omlyclo
Generic name: omalizumab Drug class: selective immunosuppressants |
||
|
Osenvelt
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
||
|
pioglitazone
Generic Drug class: thiazolidinediones |
53 reviews | 4.6 / 10 |
|
risperidone
Generic Drug class: atypical antipsychotics |
731 reviews | 5.6 / 10 |
|
Steqeyma
Generic name: ustekinumab Drug class: interleukin inhibitors |
||
|
Stoboclo
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
||
|
Temixys
Generic name: lamivudine/tenofovir disoproxil Drug class: antiviral combinations |
||
|
Truxima
Generic name: rituximab Drug class: CD20 monoclonal antibodies |
3 reviews | 7.8 / 10 |
|
Vegzelma
Generic name: bevacizumab Drug class: VEGF/VEGFR inhibitors |
||
|
Yuflyma
Generic name: adalimumab Drug class: TNF alfa inhibitors |
1 review | 8.0 / 10 |
|
Zymfentra
Generic name: infliximab Drug class: TNF alfa inhibitors |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||